UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 208

Sortiert nach

U-serrated and n-serrated patterns in bullous pemphigoid, epidermolysis bullosa acquisita, and bullous lupus: A retrospective observational study

Journal of the American Academy of Dermatology, 2024-06, Vol.90 (6), p.1282-1284

2024

Link zum Volltext

Verfügbarkeit prüfen

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Proceedings of the National Academy of Sciences - PNAS, 2015-03, Vol.112 (11), p.E1297-E1306

2015

Link zum Volltext

Verfügbarkeit prüfen

Epidermolysis bullosa acquisita involving the vulva

American journal of obstetrics and gynecology, 2024-01, Vol.230 (1), p.99-100

2024

Link zum Volltext

Verfügbarkeit prüfen

Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)

Journal of dermatology, 2019-12, Vol.46 (12), p.1102-1135

2019

Link zum Volltext

Verfügbarkeit prüfen

Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab

Journal of the European Academy of Dermatology and Venereology, 2024-01, Vol.38 (1), p.e45-e47

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib

JAMA dermatology (Chicago, Ill.), 2023-03, Vol.159 (3), p.342

2023

Link zum Volltext

Verfügbarkeit prüfen

Epidermolysis bullosa acquisita

Clinics in dermatology, 2012, Vol.30 (1), p.60-69

2012

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases

Frontiers in immunology, 2018-02, Vol.9, p.248-248

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury

The Journal of pathology, 2012-09, Vol.228 (1), p.8-19

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study

Acta dermato-venereologica, 2024-01, Vol.104, p.adv11917-adv11917

2024

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita

Frontiers in immunology, 2024, Vol.15, p.1343299-1343299

2024

Link zum Volltext

Verfügbarkeit prüfen

The use of rituximab in treatment of epidermolysis bullosa acquisita: Three new cases and a review of the literature

Dermatologic therapy, 2018-11, Vol.31 (6), p.e12726-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita

American journal of clinical dermatology, 2020-08, Vol.21 (4), p.557-565

2020

Link zum Volltext

Verfügbarkeit prüfen

A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy

Experimental dermatology, 2023-07, Vol.32 (7), p.934-944

2023

Link zum Volltext

Verfügbarkeit prüfen

Epidermolysis Bullosa Acquisita in a patient with End Stage Renal Disease: Case study

Journal of the Pakistan Medical Association, 2023-02, Vol.73 (2), p.405-406

2023

Link zum Volltext

Verfügbarkeit prüfen

Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita

Journal of investigative dermatology, 2020-12, Vol.140 (12), p.2408-2420

2020

Link zum Volltext

Verfügbarkeit prüfen

The pathogeneses of pemphigus and pemphigoid diseases

Journal of dermatological science, 2021-12, Vol.104 (3), p.154-163

2021

Link zum Volltext

Verfügbarkeit prüfen

Bullous autoimmune dermatoses

Journal der Deutschen Dermatologischen Gesellschaft, 2018-11, Vol.16 (11), p.1339-1358

2018

Link zum Volltext

Verfügbarkeit prüfen

Comment on 'Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease'

Clinical and experimental dermatology, 2023-07, Vol.48 (8), p.930-931

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita

JAMA dermatology (Chicago, Ill.), 2021-08, Vol.157 (8), p.917

2021

Link zum Volltext

Verfügbarkeit prüfen

Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology

Anais brasileiros de dermatología, 2019-04, Vol.94 (2 Suppl 1), p.33-47

2019

Link zum Volltext

Verfügbarkeit prüfen

Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses?

Journal of investigative dermatology, 2020-12, Vol.140 (12), p.2326-2329

2020

Link zum Volltext

Verfügbarkeit prüfen

PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita

Journal of investigative dermatology, 2016-11, Vol.136 (11), p.2211-2220

2016

Link zum Volltext

Verfügbarkeit prüfen

Topically Applied Hsp90 Blocker 17AAG Inhibits Autoantibody-Mediated Blister-Inducing Cutaneous Inflammation

Journal of investigative dermatology, 2017-02, Vol.137 (2), p.341-349

2017

Link zum Volltext

Verfügbarkeit prüfen

Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets

Blood, 2011-06, Vol.117 (23), p.6135-6142

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(163)

Publikationsform

Artikel
(208)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(200)
Science & Technology
(174)
Life Sciences & Biomedicine
(173)
Epidermolysis Bullosa Acquisita - Drug Therapy
(155)
Dermatology
(145)
Male
(92)
Female
(90)
Epidermolysis Bullosa Acquisita - Diagnosis
(74)
Epidermolysis Bullosa Acquisita - Pathology
(73)
Epidermolysis Bullosa Acquisita
(59)
Biological And Medical Sciences
(55)
Medical Sciences
(55)
Epidermolysis Bullosa Acquisita - Immunology
(54)
Middle Aged
(53)
Adult
(49)
Treatment Outcome
(44)
Aged
(41)
Autoimmune Diseases - Drug Therapy
(38)
Bullous Diseases Of The Skin
(38)
Drug Therapy, Combination
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

U-serrated and n-serrated patterns in bullous pemphigoid, epidermolysis bullosa acquisita, and bullous lupus: A retrospective observational study

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Epidermolysis bullosa acquisita involving the vulva

Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)

Persistence of IgG4 as a potential serological marker of disease activity in patients with epidermolysis bullosa acquisita treated with rituximab

Treatment of Recurrent Epidermolysis Bullosa Acquisita With Tofacitinib

Epidermolysis bullosa acquisita

Effectiveness and Safety of Rituximab in Recalcitrant Pemphigoid Diseases

Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury

Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study

Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita

The use of rituximab in treatment of epidermolysis bullosa acquisita: Three new cases and a review of the literature

A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita

A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy

Epidermolysis Bullosa Acquisita in a patient with End Stage Renal Disease: Case study

Propranolol Is an Effective Topical and Systemic Treatment Option for Experimental Epidermolysis Bullosa Acquisita

The pathogeneses of pemphigus and pemphigoid diseases

Bullous autoimmune dermatoses

Comment on 'Onset of epidermolysis bullosa acquisita under therapy with ustekinumab for the treatment of Crohn disease'

Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita

Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology

Propranolol Off-Target: A New Therapeutic Option in Neutrophil-Dependent Dermatoses?

PDE4 Inhibition as Potential Treatment of Epidermolysis Bullosa Acquisita

Topically Applied Hsp90 Blocker 17AAG Inhibits Autoantibody-Mediated Blister-Inducing Cutaneous Inflammation

Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets

Suchergebnisse filtern